Caricamento...
New Drugs on the Block—Emerging Treatments for Nonalcoholic Steatohepatitis
Patients with nonalcoholic steatohepatitis (NASH) are at higher risk of progression to advanced stages of fibrosis, cirrhosis, hepatocellular carcinoma and other end-stage liver disease complications. When addressing treatment of NASH, we have limited approved options, and the mainstay of therapy is...
Salvato in:
| Pubblicato in: | J Clin Transl Hepatol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
XIA & HE Publishing Inc.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868699/ https://ncbi.nlm.nih.gov/pubmed/33604255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2020.00057 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|